title: New-onset uveitis during CTLA-4 blockade therapy with ipilimumab in metastatic melanoma patient.
authors: San Raffaele Scientific Institute, University Vita-Salute, Milan, Italy. Electronic address: miserocchi.elisabetta@hsr.it.
authors: Elisabetta
authors: E
authors: Miserocchi
authors: San Raffaele Scientific Institute, University Vita-Salute, Milan, Italy.
authors: Carolina
authors: C
authors: Cimminiello
authors: San Raffaele Scientific Institute, University Vita-Salute, Milan, Italy.
authors: Marco
authors: M
authors: Mazzola
authors: San Raffaele Scientific Institute, University Vita-Salute, Milan, Italy.
authors: Vincenzo
authors: V
authors: Russo
authors: San Raffaele Scientific Institute, University Vita-Salute, Milan, Italy.
authors: Giulio M
authors: GM
authors: Modorati
mesh_terms: D000368:Aged; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D060908:CTLA-4 Antigen / Q000037:antagonists & inhibitors*; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D000074324:Ipilimumab; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000556:secondary; D008545:Melanoma / Q000188:drug therapy* / Q000556:secondary; D009184:Mydriatics / Q000627:therapeutic use; D011239:Prednisolone / Q000031:analogs & derivatives / Q000627:therapeutic use; D014331:Tropicamide / Q000627:therapeutic use; D014604:Uveal Neoplasms / Q000188:drug therapy* / Q000473:pathology; D014606:Uveitis, Anterior / Q000139:chemically induced* / Q000188:drug therapy; D014786:Vision Disorders / Q000139:chemically induced / Q000188:drug therapy; D014792:Visual Acuity
chemical_list: D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D060908:CTLA-4 Antigen; C556706:CTLA4 protein, human; D005938:Glucocorticoids; D000074324:Ipilimumab; D009184:Mydriatics; C009935:prednisolone acetate; D011239:Prednisolone; D014331:Tropicamide